SILVERARC CAPITAL MANAGEMENT, LLC
73 holdingsFiling period: 2026-06-30Current AUM: $896.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | — | ASCENDIS PHARMA A/S | 206.2K | $55.0M | $55.0M | 6.13% | -- | 2026-06-30 |
| 2 | CELC | CELCUITY INC | 501.0K | $52.4M | $41.4M | 4.62% | +143.1K | 2026-06-30 |
| 3 | COGT | COGENT BIOSCIENCES INC | 1.28M | $49.6M | $41.9M | 4.68% | -33,482 | 2026-06-30 |
| 4 | — | UROGEN PHARMA LTD | 1.30M | $47.9M | $47.9M | 5.34% | -201,066 | 2026-06-30 |
| 5 | IMNM | IMMUNOME INC | 2.02M | $42.7M | $48.3M | 5.39% | +166.7K | 2026-06-30 |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | 390.0K | $38.0M | $40.9M | 4.56% | -264,746 | 2026-06-30 |
| 7 | RYTM | RHYTHM PHARMACEUTICALS INC | 311.5K | $34.6M | $30.1M | 3.36% | +5.5K | 2026-06-30 |
| 8 | ORKA | ORUKA THERAPEUTICS INC | 352.8K | $33.6M | $32.5M | 3.63% | +201.9K | 2026-06-30 |
| 9 | GLUE | MONTE ROSA THERAPEUTICS INC | 1.11M | $26.8M | $14.4M | 1.61% | -893,745 | 2026-06-30 |
| 10 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.21M | $26.5M | $22.0M | 2.45% | +325.4K | 2026-06-30 |
| 11 | ELVN | ENLIVEN THERAPEUTICS INC | 489.4K | $24.8M | $26.1M | 2.91% | -- | 2026-06-30 |
| 12 | IMVT | IMMUNOVANT INC | 619.1K | $23.9M | $22.7M | 2.53% | +204.9K | 2026-06-30 |
| 13 | ERAS | ERASCA INC | 1.26M | $23.1M | $20.5M | 2.29% | -588,786 | 2026-06-30 |
| 14 | SGMT | SAGIMET BIOSCIENCES INC | 2.93M | $22.6M | $30.6M | 3.41% | -- | 2026-06-30 |
| 15 | ABVX | ABIVAX SA | 169.6K | $22.6M | $18.1M | 2.02% | -132,937 | 2026-06-30 |
| 16 | PRAX | PRAXIS PRECISION MEDICINES I | 65.7K | $22.0M | $20.6M | 2.29% | -5,873 | 2026-06-30 |
| 17 | KOD | KODIAK SCIENCES INC | 546.3K | $21.3M | $18.0M | 2.01% | -445,674 | 2026-06-30 |
| 18 | ARKK | ARK ETF TR | 500.0K | $21.0M | $21.7M | 2.42% | -- | 2026-06-30 |
| 19 | DFTX | DEFINIUM THERAPEUTICS INC | 400.0K | $18.8M | $14.7M | 1.64% | -- | 2026-06-30 |
| 20 | VCYT | VERACYTE INC | 318.0K | $18.7M | $12.8M | 1.42% | +138.3K | 2026-06-30 |
| 21 | SNDX | SYNDAX PHARMACEUTICALS INC | 693.6K | $15.2M | $12.5M | 1.40% | +373.6K | 2026-06-30 |
| 22 | GH | GUARDANT HEALTH INC | 99.8K | $15.0M | $17.5M | 1.96% | +1.3K | 2026-06-30 |
| 23 | CCCC | C4 THERAPEUTICS INC | 3.03M | $14.2M | $10.4M | 1.16% | +1.12M | 2026-06-30 |
| 24 | ZBIO | ZENAS BIOPHARMA INC | 509.8K | $12.9M | $16.3M | 1.81% | -626,146 | 2026-06-30 |
| 25 | TRVI | TREVI THERAPEUTICS INC | 678.1K | $12.6M | $10.2M | 1.14% | +167.0K | 2026-06-30 |
← Scroll →
Page 1 of 3